We’re proud to announce that Healios has closed a £14 million funding round to deliver online mental health, autism and ADHD services to children and young people in the USA and UK.
Existing investors AlbionVC and InHealth Ventures joined this latest round, along with new investor Autism Impact Fund.
The funding will support the multi-state expansion of our US subsidiary Meliora Health, which currently provides care in New York and Pennsylvania. It will also be used to develop new assessment and intervention programmes and advance machine learning, data science and clinical research across the two companies.
“Healios and Meliora’s unique model combines a multidisciplinary team with our innovative online platform, evidence-based treatments, and a family-centric approach to address a range of complex clinical needs of children and young people.”